RECIP Publications

Jul 11, 2023

Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer

Andrei Gafita , Loïc Djaileb, Isabel Rauscher, Wolfgang P. Fendler, Boris Hadaschik, Steven P. Rowe, Ken Herrmann, Jeremie Calais, Matthew Rettig, Matthias Eiber, Manuel Weber, Matthias R. Benz, Andrea Farolfi

Learn more



Medical

Nov 1, 2022

Novel framework for treatment response evaluation using PSMA PET/CT in patients with metastatic castration-resistantprostate cancer (RECIP 1.0): an international multicenter study

Andrei Gafita, Isabel Rauscher, Manuel Weber, Boris Hadaschik, Hui Wang, Wesley R. Armstrong, Robert Tauber, Tristan R. Grogan, Johannes Czernin, Matthew B. Rettig, Ken Herrmann, Jeremie Calais, Wolfgang A. Weber, Matthias R. Benz, Wolfgang P. Fendler and Matthias Eiber

Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria

Andrei Gafita, Isabel Rauscher, Wolfgang P. Fendler, Vishnu Murthy, Wang Hui, Wesley R. Armstrong, Ken Herrmann, Wolfgang A. Weber, Jeremie Calais, Matthias Eiber, Manuel Weber & Matthias R. Benz

PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors

Qaid Ahmed Shagera, Ioannis Karfis, Paulus Kristanto, Sideris Spyridon, Romain Diamand, Albert Santapau, Alexandre Peltier, Thierry Roumeguère, Patrick Flamen, Carlos Artigas

Prognostic utility of RECIP 1.0 with manual and AI-based 68 segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images

Jake Kendrick, Roslyn J. Francis, Ghulam Mubashar Hassan, Pejman Rowshanfarzad, Jeremy Sl Ong, Michael McCarthy, Sweeka Alexander, Martin A. Ebert

Prognostic Performance of RECIP 1.0 Based on [18F]PSMA-1007 PET in Prostate Cancer Patients Treated with [177Lu]Lu-PSMA I&T

Philipp E Hartrampf, Thomas Hüttmann, Anna Katharina Seitz, Hubert Kübler, Sebastian E. Serfling, Takahiro Higuchi, Wiebke Schlötelburg, Kerstin Michalski, Andrei Gafita, Steven P. Rowe, Martin G. Pomper, Andreas K. Bu

Prognostic Value of Tumor Volume Assessment on PSMA PET After 177Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0

Felix Kind, Ann-Christin Eder, Cordula A Jilg, Philipp E Hartrampf, Philipp T Meyer, Juri Ruf, Kerstin Michalski

Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis

Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin, Jeremie Calais

Learn more

